Research Collaboration Grants are two-year, $200,000 grants for multi-investigator and multi-institutional brain tumor collaborative research projects. They are intended to promote team science, streamlining and accelerating research progress.
Research projects must be conducted by a team of at least two co-principal investigators (Co-PI’s) from different institutions. The research project should be multidisciplinary, incorporating multiple components such as basic, translational, clinical, and epidemiological research.
Please note: Due to the impact of the COVID-19 pandemic, the ABTA is not able to accept applications for the Research Collaboration Grants for the 2022 grant cycle.
Applications for the ABTA Research Collaboration Grants are typically accepted every other year. Applications are pre-screened by Letter of Intent, due in December. Invitations and instructions to submit a Full Application are extended by email in February, with an application due date in March.
Your research can make a difference
With their 2017 ABTA Research Collaboration Grant, Ben Ellingson, PhD and Elizabeth Gerstner, MD are using diffusion MRI to determine whether they can predict which recurrent glioblastoma patients can benefit from anti-angiogenic therapy. Through a retrospective analysis of 5 individual multicenter clinical trials, they discovered a correlation between tumors with a high Apparent Diffusion Coefficient and longer survival among rGBM patients on anti-angiogenic monotherapy. Their findings have been published in Clinical Cancer Research. This research team is moving forward with a prospective multicenter clinical trial to validate these findings, and a surgical study to better understand the mechanisms underlying this effect.